Cited by 552Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesSmoking Behavior and Cessation

The DOI matches its Crossref record; 340 of the 341 references it cites were found in a registry or an index.

Cannabis use and cannabis use disorder

Open access

Connor, Jason P., Stjepanović, Daniel, Le Foll, Bernard, Hoch, Eva, Budney, Alan J., Hall, Wayne D.·2021·Nature Reviews Disease Primers

DOI 10.1038/s41572-021-00247-4PMC PMC8655458

Open this paper in CoChat — free account

Abstract

Cannabis use disorder (CUD) is an underappreciated risk of using cannabis that affects ~10% of the 193 million cannabis users worldwide. The individual and public health burdens are less than those of other forms of drug use, but CUD accounts for a substantial proportion of persons seeking treatment for drug use disorders owing to the high global prevalence of cannabis use. Cognitive behavioural therapy, motivational enhancement therapy and contingency management can substantially reduce cannabis use and cannabis-related problems, but enduring abstinence is not a common outcome. No pharmacotherapies have been approved for cannabis use or CUD, although a number of drug classes (such as cannabinoid agonists) have shown promise and require more rigorous evaluation. Treatment of cannabis use and CUD is often complicated by comorbid mental health and other substance use disorders. The legalization of non-medical cannabis use in some high-income countries may increase the prevalence of CUD by making more potent cannabis products more readily available at a lower price. States that legalize medical and non-medical cannabis use should inform users about the risks of CUD and provide information on how to obtain assistance if they develop cannabis-related mental and/or physical health problems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41572-021-00247-4

Cites

340 of 340 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Timeline Follow-Back
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
ADOLESCENT RESILIENCE: A Framework for Understanding Healthy Development in the Face of Risk
Fergus, S., & Zimmerman, M. A. (2004) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144357 · Cited by 3,243
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Show all 341 references

Research works printed but not linked: 13

Hall, W., Renström, M. & Poznyak, V. The Health and Social Effects of Nonmedical Cannabis Use (World Health Organization, 2016). This is a seminal review of the short-term and long-term effects of cannabis use and CUD on health.
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, & Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (National Academies Press, 2017).
Compton, W. M. & Han, B. in The Complex Connection between Cannabis and Schizophrenia (eds Compton, M. & Manseau, M.) (Academic Press, 2017).
Connor, J. P., Feeney, G. F. X., Kelly, A. B. & Saunders, J. B. in The SAGE Handbook of Drug & Alcohol Studies. Volume 2, 283–305 (SAGE Publications, 2016).
Howlett, A. C. in Cannabinoids. Handbook of Experimental Psychology, vol 168 (ed. Pertwee, R. G.) 53–79. (Springer, 2005).
Trick, L. et al. in PET and SPECT in Psychiatry 2nd edn (eds Dierckx, R. A. J. O., Otte, A., de Vries, E. F. J., van Waarde, A. & Sommer, I. E.) 653–712 (Springer, 2020).
McMurran, M. The Psychology of Addiction (Routledge, 1994).
American Psychiatric Association. Substance-related and addictive disorders. in Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2013). · DOI · Paper page
Connor, J. P., Saunders, J. B. & Feeney, G. F. X. in Quality of Life in Mental Disorders (eds Katschnig, H., Freeman, H. L. & Sartorius, N.) 199–208 (John Wiley & Sons, 2006).
Longabaugh, R., Magill, M., Morgenstern, J. & Huebner, R. in Addictions: A Comprehensive Guidebook (eds McCrady, B. S. & Epstein, E. E.) 572–596 (Oxford University Press, 2013).
Marlatt, G. A., & Donovan, D. M. (eds) Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors (Guilford Press, 1985).
Saunders, J. B. et al. (eds) Addiction Medicine (Oxford University Press, 2016).
Ries, N. M. Prescribe with caution: the response of canada’s medical regulatory authorities to the therapeutic use of cannabis. McGill J. Law Health 9, 215–254 (2016).

Sorted by citations

Items 401–500 of 552

Cannabidiol (CBD) Listed as a Drug of Abuse by the Italian Health Ministry: Expert Opinion
Comacchio, C., Balestrieri, M., & Colizzi, M. (2024) · Current Social Sciences · doi:10.2174/012772316x295557240417104307
Cannabis Use Disorder
Campbell, A. L., George, G., & Marpuri, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_17
Drugs are Nation’s Enemy: BNN Demanded to Implement P4GN Policy in Reducing Prevalence Rate
Kartini, K., Umami, R., Putri, A. S., Khumayah, S., & Imawan, K. (2024) · Devotion Journal of Research and Community Service · doi:10.59188/devotion.v5i5.728
Cannabis use in the COVID-19 pandemic: Changes in different populations and implications for policy
Zaweel, A., Kuk, I., Kim, S., Foll, B. L., & Wickens, C. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95650-5.00017-3
Current options for cannabinoids in the treatment of Parkinson's disease
Zdziebło, P., Machała-Ćwikła, E., Łapińska, U., Ćwikła, P., Machała, K., Zdziebło, A., Machała, D., Zdziebło, K., & Bieniasz, A. (2024) · Quality in Sport · doi:10.12775/qs.2024.17.52922
Disorders due to Substance Use: Cannabis
Cousijn, J., Compton, W. M., & LEVIN, F. R. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_161
The Impact of Potent Addictive Substances on Angiogenic Behavior: A Comprehensive Review
AL-Eitan, L. N., Alahmad, S. Z., & Khair, I. Y. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666240905125037
Therapeutic Efficacy of Cannabis in the Management of Chronic Pain: An Opinion Paper
Polito, G., Zovi, A., Coluccia, A., Vaccaro, M., Bagaglini, G., Capuozzo, M., Langella, R., Zavaleta‐Monestel, E., Quesada-Villaseñor, R., & Ferrara, F. (2024) · Current Drug Therapy · doi:10.2174/0115748855319068240915174752
Cannabis Use Disorders: Measuring Usage
Lac, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_88-1
Treatment of Substance Use Disorders in Post-ICU Settings
Marcoux, S. V. (2024) · Springer eBooks · doi:10.1007/978-3-031-67069-5_10
Efectos y prevalencia del consumo simultáneo de alcohol y cannabis: una revisión narrativa
Martínez-Peña, A. A. (2024) · Revista Internacional de Investigación en Adicciones · doi:10.28931/riiad.2024.2.11
Cannabis und Cannabinoide
Hoch, E., Hämmig, R., & Preuss, U. W. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21074-7.00012-5
Commentary on Qeadan et al .: Leveraging opportunities to expand the substance use disorder treatment arsenal
Schepis, T. S. (2024) · Addiction · doi:10.1111/add.16725
Cannabis und Nikotin in deutschen Musikvideos
Hanewinkel, R., Neumann, C., & Morgenstern, M. (2024) · Pneumologie · doi:10.1055/a-2486-6646
Cannabis: A Drug of Addiction
Bourin, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-72219-6_20
The Association Between Past 12-Month Synthetic Cannabinoid Polysubstance Use and Cannabis Use Disorder in a Nationally Representative US Sample
Qin, W. A., Seo, D., Lee, S. H., & Elam, K. K. (2025) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01430-w
Prolonged incubation with Δ9-tetrahydrocannabinol but not with cannabidiol induces synaptic alterations and mitochondrial impairment in immature and mature rat organotypic hippocampal slices
Mazzantini, C., Curti, L., Lana, D., Masi, A., Giovannini, M. G., Magni, G., Pellegrini-Giampietro, D. E., & Landucci, E. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117797
Practical Matters: Cannabis Formulations and Dosing
Sera, L., & Hempel‐Sanderoff, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-80352-9_8
Substanzkonsum 14- bis 17-Jähriger vor, während und nach der COVID-19-Pandemie – Ergebnisse der schulbasierten Fragebogenstudie Präventionsradar
Hansen, J., & Hanewinkel, R. (2025) · Diskurs Kindheits- und Jugendforschung / Discourse Journal of Childhood and Adolescence Research · doi:10.3224/diskurs.v19i4.03
A Modern Clinician’s Approach to the Medical Cannabis Era
Sera, L., & Hempel‐Sanderoff, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-80352-9_7
Expanding treatment domains across psychiatric disorders
Serretti, A. (2025) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000581
The role of impulsivity in the association between rumination and cannabis‐related problems among trauma‐exposed cannabis users
Le, J. U., Deguzman-Lucero, R. M., Schmidt, N. B., & Short, N. A. (2025) · British Journal of Clinical Psychology · doi:10.1111/bjc.12530
Obsessive-Compulsive Disorder: Linking with Cannabis Use and Misuse
Kutzner, J., Qureshi, L., & Bettinger, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_76-1
Substance Use Disorders
Mangum, A., Ling, D., & Velasquez, M. M. (2025) · Oxford University Press eBooks · doi:10.1093/obo/9780195389678-0342
Relation of Cannabis Use Frequency and Gambling Behavior in Individuals Who Gamble Under the Influence of Cannabis
McPhail, A., Whelan, J., Ginley, M. K., & Pfund, R. A. (2025) · Journal of Gambling Studies · doi:10.1007/s10899-025-10381-3
Rasch Analysis of Cannabis Use Disorder in an Adult Inpatient Sample
Gendy, M. N. S., Taisir, R., Britton, E. M., Costello, M. J., & MacKillop, J. M. (2025) · Cannabis · doi:10.26828/cannabis/2025/000229
Epidemiology and Health Impacts of Substance Use
Reichert, R. A., Boos, F. Z., Lopes, F. M., & de MICHELI, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-82614-6_3
Evolución de las campañas institucionales de comunicación social de alcohol, drogas y fármacos sobre seguridad vial en España
Faus, M., Alonso, F., Estéban, C., & Tortosa, M. (2025) · Revista Española de Drogodependencias · doi:10.54108/10107
Comorbid Cannabis Use and Mood Disorders Among Adolescents
Strong, S. J., Thomas, H. A., Adams, Z. W., & Hulvershorn, L. A. (2025) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20240049 · Cited by 1
Cannabisprävention: Legal, aber … lost?! Wie Plakate mehr verwirren als angemessen aufklären
Ruck, J., & Simmenroth, A. (2025) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2025.03.009
Substance Use and Clinical Correlates of Opioid Dependence: A Multifactorial AnalysisPreprint
Hatwiko, H., Masta, D. N., Baines, S. M., Kurehwatira, K. R., Mulambo, P., Riwo, E. O., Ngongo, N. N., Yumba, E., Nature, M., Mwangelwa, M., et al. (2025) · medRxiv · doi:10.1101/2025.05.14.25327645
Understanding the influence of parent-child conversations about dangers of drug use on cannabis use among high school students in Barbados
Oshi, S. N., Espinoza-Hidrobo, M. I., Pozo-Neira, J., & Cabrera-Arias, S. (2025) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_669_24
Who Seeks Help? A Sociodemographic Analysis of Cannabis Use Disorder Treatment in New York
Atolagbe, A., Emembolu, E. T., & Nkemjika, S. (2025) · Psychoactives · doi:10.3390/psychoactives4020017
APLICAÇÃO TERAPÊUTICA DO CANABIDIOL NO MANEJO DO DIABETES MELITTUS TIPO 2
Nunes, H. F., de Melo, C. V. B., & Santana, A. C. S. G. V. (2025) · Revista Contemporânea · doi:10.56083/rcv5n6-048
Young adult cannabis use and circulating endocannabinoid concentrations on cognitive performance
Wallace, A. L., Baca, R. E., Andrade, G., Hillard, C. J., Happer, J. P., Wade, N. E., Courtney, K. E., Mejia, M. H., & Jacobus, J. (2025) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2025.1538448
Cannabis Use Disorder: A Review on Clinical Management
de Macedo, R. R. B., Rodrigues, D. R., Kainaki, A. P. F., Kassem, P. D. L., Barros, R. A., Catrolio, A. F., Barbosa, J. M. D., Junior, M. A. A. D. A., Bergamo, F. M. D. A., Garcia, L. T. S., et al. (2025) · International Journal of Health Science · doi:10.22533/at.ed.1595262514078
A Qualitative Investigation Into the Experiences of Medicinal Cannabis Use Among Chronic Pain and PTSD Patients in Israel
Gliksberg, O., Hulaihel, A., Sznitman, S. R., Brill, S., Amit, B. H., Lev‐Ran, S., Kushnir, T., & Feingold, D. (2025) · Qualitative Health Research · doi:10.1177/10497323251361328
Recreational Drugs: Alcohol, Marijuana, Nicotine
Bilder, G. E., & Brown-O’Hara, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-84831-5_8
Predictors of engagement and dropout in the context of joint treatment for dual disorders: An exploratory analysis
Spagnuolo, A. S., Boy, O. B., Noschese, I., Porcinai, N., Elia, F., Castellini, G., Rotella, F., Ricca, V., Lanzi, C., Occupati, B., et al. (2025) · Heroin addiction and related clinical problems · doi:10.62401/2531-4122-2025-22
Validación de la escala CUDIT-R para detectar comportamientos peligrosos asociados al uso de cannabis en población latinoamericana
Cárdenas, A. R. V., & Bello, N. F. S. (2025) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2025.4097/2023
Cannabis Use Disorders: Measuring Usage
Lac, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_88
Obsessive-Compulsive Disorder: Linking with Cannabis Use and Misuse
Kutzner, J., Qureshi, L., & Bettinger, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_76
The Role of Digital Technologies in Enhancing Advertising Imagery for Combating Drug Abuse: an Analytical Study of Ministry of Interior Advertisements
Ajeel, A. C., Ajil, I. A., & Mohammed, S. F. (2025) · IEEE International Conference on Computing and Machine Intelligence (ICMI) · doi:10.1109/icmi65310.2025.11141270
Delayed-Onset Delirium Tremens in the Context of Co-occurring Benzodiazepine Use Disorder: A Case Report
Lima, J. G. C., Gay, M. E., & Buciuc, A. G. (2025) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2025.210103
Individual differences in the pharmacokinetic profiling of Δ9-THC may be associated with differential motivational effects of Δ9-THC on cognitive performancePreprint
Myers, T. M., Neverette, N. C., Devanathan, A. S., & Torregrossa, M. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.30.679373
Associations Among Minority Stress, Relaxation and Tension-Reduction Motives, and Cannabis Use Among a Sample of Sexual and Gender Minority Adults in Oklahoma
Sikora, N., Romm, K. F., Smith, M. A., & Cohn, A. M. (2025) · Substance Use & Addiction Journal · doi:10.1177/29767342251374755
Perceived Ethnic Discrimination and Negative Emotional Reactivity to Minority Stress: Association with Cannabis Use Processes Among United States Hispanic/Latinx Adults
Zvolensky, M. J., Clausen, B. K., Jones, A. A., Castillo-Avilés, R., Thai, J. M., Shepherd, J. M., Bogiaizian, L., Redmond, B. Y., & Garey, L. (2025) · Cannabis · doi:10.26828/cannabis/2025/000335
Marijuana
Cherchi, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-94841-1_164
Nutritional Strategies for Specific Substance Use Disorders
Na’Allah, A., Yusuf, B. O., Moronfolu, I. A., & Sabiu, S. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-1414-4_17
Back on track: Feasibility and efficacy randomized trial of a two-week online self-guided intervention for cannabis use reduction
Kroon, E., Elsey, J. W. B., Kuhns, L., Rietveld, P., de Vries, O. T., Larsen, H., Wiers, R. W. H. J., & Cousijn, J. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112943
Managing substance abuse on psychiatric units: a scoping review
Hudon, A., Cloutier-Tanguay, J.-P., Levy, J., Dastous-Stampe, W., Daigneault, M.-L., Lacombe, C., Noël, F., & Pagé, S. B. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1653093
Medicinal cannabinoid use and the risk of developing psychoses and suicidality
Silva, J. P., & Carvalho, F. D. (2025) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2025.100551
Multi-Modal Cannabis Use and Binge Drinking Outcomes Among 12 th Grade Students in the United States, A Cross-Sectional Analysis from 2018-2021
Goulette, M. R., Haney, A. M., Homish, G. G., & Kulak, J. A. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2581244
The association between cannabis use and romantic relationship satisfaction: The role of intensity, concordance, and sex differences
Ashwal-Malka, A., Braw, Y., Nataf, H., & Feingold, D. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112956
Exploring the Link: Marijuana Use Patterns and Their Impact on Coronary Heart Disease Risk
Wei, T., Shen, S., Shan, T., Wan, T., Liang, Y., Lin, Z., Sun, Y., Li, Y., & Zhang, Q. (2025) · Clinical Cardiology · doi:10.1002/clc.70223
Association of Cannabis and Cigarette Use With Eustachian Tube Dysfunction
Hori, K., Cobian, A. G., Gallagher, T. J., & Choi, J. S. (2025) · Otology & Neurotology · doi:10.1097/mao.0000000000004756
A mindfulness-based intervention to reduce altered brain reward function in cannabis use disorder: a double-blind, active and passive, randomised controlled fMRI trial
Beyer, E., Skumlien, M., Poudel, G. R., Arun, A. H., McTavish, E., Thomson, H. M., Sehl, H., Segrave, R. A., Clemente, A., Labuschagne, I., et al. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07073-0
Cross-sectional comparison of cannabis use in adults with neuropathic versus non-neuropathic pain
Laroya, C. J., Smith, C. L., Bindler, R. J., McDonell, M. G., Lewis, J., & Wilson, M. (2025) · Frontiers in Pain Research · doi:10.3389/fpain.2025.1677391
Controlled Use of Cannabis Among Young Adults in Los Angeles Across Changes in Cannabis Policies
Lankenau, S. E., Ataiants, J., Prince, M. A., Fedorova, E. V., Conn, B. M., Ansell, E. B., & Wong, C. F. (2025) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-025-01608-w
Additional file 2 of No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users
Rydberg, A., Dodoo, C. A., Schneekloth, T. D., & Abulseoud, O. A. (2023) · Figshare · doi:10.6084/m9.figshare.23543225
Additional file 1 of “I don’t need my kid to be high”: prioritizing harm reduction when using cannabis during pregnancy
Gould, E. E., Ganesh, S. S., & Ceasar, R. C. (2024) · Figshare · doi:10.6084/m9.figshare.26974354
Additional file 1 of No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users
Rydberg, A., Dodoo, C. A., Schneekloth, T. D., & Abulseoud, O. A. (2023) · Figshare · doi:10.6084/m9.figshare.23543222
Additional file 2 of “I don’t need my kid to be high”: prioritizing harm reduction when using cannabis during pregnancy
Gould, E. E., Ganesh, S. S., & Ceasar, R. C. (2024) · Figshare · doi:10.6084/m9.figshare.26974357
Instrumentos para rastreio de transtornos mentais por substâncias psicoativas na atenção primária: revisão de escopo
de Morais, N. M., Silva, A. C. M., Sousa, J. M., Nogueira, L. E. F. L., & Caixeta, C. C. (2025) · Journal of Nursing and Health · doi:10.15210/jonah.v15i3.28130
Racial diversity in cannabis use disorder research: A systematic review
Reid, M. R., Reynolds, B., Cape, J. R., Ahmed, Z., Ali, H., Jaimes-Bautista, E., Gott, C., Barajas, A., Müller, F., & Alshaarawy, O. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.113008
Cannabinoid Use Among Adult Women: A Scoping Review
Trice, C., Prebihalo, S. E., Rattan, S., Spencer, K., Karasick, A., Scott-Richardson, M., Punzalan, C., Gensheimer, K. F., Markon, A. O., South, E. M., et al. (2025) · Journal of Women s Health · doi:10.1177/15409996251385404
Sex and gender influences on problematic cannabis use and cannabis use disorder: A scoping review protocol
Matheson, J., Mielnik, C. A., Knight, R., Wright, M., Marley, N., Bonato, S., Foll, B. L., Gallagher, L., & Rubin-Kahana, D. S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0327704 · Cited by 1
Cannabis use disorders - new challenges for health systems in West Africa: a narrative review
Ane, M. (2025) · Journal de gestion et d économie médicales · doi:10.54695/jdds.043.1.0023
Associations between cannabis use, cannabis use motivations and past year polysubstance use among people living with HIV in Florida
McNeely, K. V., Seegulam, V. L., Cook, R. L., Zhou, Z., Wang, Y., Porges, E. C., Cohen, R. A., Somboonwit, C., Sherbuk, J. E., Ibanez, G., et al. (2026) · AIDS Care · doi:10.1080/09540121.2026.2614344
Prenatal Cannabis Exposure Shaping Altered Brain Connectivity: Neural Correlates of Cognitive and Mental Health Variability in OffspringPreprint
Fu, Z., Hutchison, K. E., Guha, A., Jing Sui （Beijing Normal University）， my correct affiliation is beijing normal university, N. Q. U. O. S. A. T., & Calhoun, V. (2026) · Research Square · doi:10.21203/rs.3.rs-8545326/v1
Cannabis Use Motives and Cannabis-Related Outcomes: A Moderated Moderation Analysis of Protective Behavioral Strategies and Sex
Romero-Pérez, N., Parrado‐González, A., González‐Ponce, B. M., & Fernández‐Calderón, F. (2026) · Journal of Drug Issues · doi:10.1177/00220426261419789 · Cited by 1
Illicit cannabis use among workers in Australia: A nationally representative cross-sectional analysis of prevalence, determinants, and associated absenteeism
Censo, G. D., Thompson, K. R., & Bowden, J. A. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113057
Blunted reward-related striatal activity and behavioral disinhibition as a pathway to adolescent cannabis and e-cigarette use
Perez, P. M. V., Hill, L. D., Crooks, K. E., Sutherland, B. D., Laird, A. R., Trucco, E. M., & Sutherland, M. T. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1741884
Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users
Bouso, J. C., Andión, Ó., Fondevila, S., González, D., Alcázar-Córcoles, M. Á., Kohek, M., SANTOS, R. G. D., Hallak, J. E. C., & Jordi Riba, A. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112782
Implikationen von Trenddaten und Leitlinien: Risikoorientiert vorbeugen und patientenorientiert behandeln
Batra, A., Gouzoulis‐Mayfrank, E., Lenz, B., Mühlig, S., Müller, A., & Rumpf, H. (2026) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/0939-5911/a000966
Effectiveness of cognitive behavioral therapy for harmful cannabis use: a systematic review and meta-analysis
Ullah, S., Ullah, A., Ahmad, F., Latif, A., Sohaib, M., Khan, M. F., Ahmad, B. M., Yadegarfar, G., Farooq, S., Naeem, F., et al. (2026) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2026.2613114
Cannabis retail environment and treatment for cannabis use disorder
Mennis, J. L., Coatsworth, J. D., Zaharakis, N. M., Riggs, N. R., Brown, A., Russell, M. A., & Mason, M. J. (2026) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2026.113096
Phase 1 Open-Label Pilot Trial of H4 Deep Repetitive Transcranial Magnetic Stimulation for Adults With Moderate-to-Severe Cannabis Use Disorder
MacKillop, J. M., McIntyre‐Wood, C., Vandehei, E., Yaya, H., Passa, A.-M. D., Prokop-Millar, S., Fein, A. J., Yang, A., Elsayed, M., Schwartzmann, B., et al. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2026.01.003
Association between venlafaxine use and the risk of withdrawal from nonopioid substances: a nationwide, population-based study
Wei, S., Li, B. M., Tsai, D. H., Hu, H.-Y., Lin, S.-Y., Lin, S.-J., Su, C., Pan, C., & Lai, E. C.-C. (2026) · Harm Reduction Journal · doi:10.1186/s12954-026-01427-9
Bidirectional association of psychopathology and cannabis use: Results from the Swiss study on recreational cannabis access via pharmacies
Mosandl, C. F., Pichler, E. M., Meyer, M., Guessoum, A., Herrmann, O., Curiger, J., Kronschnabel, J., Vogel, M., Walter, M., & Baltes‐Flueckiger, L. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121604
Prevalence of cannabis use among trauma patients presenting to the emergency department: A systematic review and meta-analysis
Wongtanasarasin, W., Oon‐arom, A., Sairai, R., & Nishijima, D. K. (2026) · Traffic Injury Prevention · doi:10.1080/15389588.2026.2623013
Factors Associated with Graduate Student Drug Use in Brazil
Mazer, L. C., Miasso, A. I., Taipe, C. M. M., Baldassarini, C. R., Martínez, E. Z., Molina, N. P. F. M., & dos Santos, P. L. (2026) · Journal of Latinos and Education · doi:10.1080/15348431.2026.2641560
The effectiveness of psychological interventions delivered by health professionals for adult cannabis use in community settings: a systematic review and meta-analysis
Giguère, S., Potvin, S., Beaudoin, M., Boudreau, X. W., Giguère, C., & Dumais, A. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1792228
Cognitive performance and subjective effects the morning after last use of smoked cannabis by adults who use cannabis frequently: An observational study
Matheson, J., Zakala, C., Zhao, S., Battistuzzi, A., Nette, A., Foll, B. L., Wickens, C. M., Wang, W., Chen, S., & Ciano, P. D. (2026) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2026.100432
Cannabis consumption and problematic internet use: analysis of a free-text response collected through a self-reported online questionnaire
St-Onge, J., Brodeur, M., Légaré, A.-A., Deschamps, A., Auger, A.-M., Gómez, N. M., Hudon, C., Jutras‐Aswad, D., Håkansson, A., Parent, V., et al. (2026) · BMC Psychology · doi:10.1186/s40359-026-04419-3
Development of a Decision Aid to Support Shared Decision-Making on Cannabis Use for Arthritis: Protocol for a Multiphase Study
Aref, H. A. T., Hamarneh, Y. N. A., Kiang, T. K. L., Yacyshyn, E., & Sadowski, C. A. (2026) · JMIR Research Protocols · doi:10.2196/76237
The risk of psychosis associated with cannabis use by people with attention-deficit hyperactivity disorder: A systematic review
Suetani, S., Honarparvar, F., Muller, P., Kesby, J. P., & Parker, S. (2026) · Australasian Psychiatry · doi:10.1177/10398562261439662
Self-reported Visual Function After Non-medical Cannabis Use: A Cross-sectional Survey
Elmadina, A. E. M., & Hagar, S. I. E. (2026) · Sudan Journal of Medical Sciences · doi:10.18502/sjms.v21i1.19228
Mieux comprendre, étudier et prendre en charge la consommation de cannabis : apports méthodologiques et facteurs de risques
Chassagne, J. F. (2023) · theses.fr (ABES) · doi:10.70675/508d7244z2b0fz400eza34ezeec1d1c8be41
Emotion regulation and cannabis use in young people: a systematic review
Fleury, R., Riaz, S., O’Higgins, F., Anih, A. N., Dooley, N., Staines, L., Healy, C., Gillan, D., Smyth, B. P., & Cannon, M. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1766637
Association between cannabis use and major depressive disorder: a population-based cross-sectional study
Ning, Y., Sun, J., Zhou, J., Wang, Y., Shang, Z., Li, M., Li, H., Sun, Y. X., Wu, Y., Assimes, T. L., et al. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-026-00396-x
Exploring Age and Sex Differences in the Use of Cannabis Vaping Products: Results From the Canadian Cannabis Survey 2020–2023
Fataar, F., Dann, M. J., Goodman, S. E., & Abramovici, H. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70155
The man who forgot his addiction: Sustained remission of cocaine use disorder following overdose-induced bilateral hippocampus stroke
MacKillop, E., McIntyre‐Wood, C., Vaughn, D. W., Sweet, L. H., & MacKillop, J. M. (2026) · The Clinical Neuropsychologist · doi:10.1080/13854046.2026.2651223
Long-term effects of adolescent THC exposure on anxiety-like behavior and cognitive function in male rats
Lumor, J. S., Nyberg, H., Nerem, E., Andersen, J. M., & Bogen, I. L. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07067-y
Extraction and Mass Spectrometry Detection of Cannabinoids in Clinical Samples
Coughlin, M., & Garelnabi, M. (2026) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575403595251119091701
Pharmacotherapy for Cannabinoid Use Disorder
Gagliardi, S. (2026) · Springer eBooks · doi:10.1007/978-3-031-57159-6_77-1
Beyond just intoxication: An exploration of the potential links between problematic cannabis use, self-reported psychological dysfunction, and subjective driving capabilities
Love, S., & Armstrong, K. A. (2026) · Journal of Safety Research · doi:10.1016/j.jsr.2026.04.016
Psychometric validation of the Cannabis Withdrawal Checklist in a Spanish sample with cannabis use disorder
Saura, J., Feliu, A., Enríquez, M., Tutusaus, X. R., Ballbè, M., Fu, M., Segura, L., Fernández, E., & Martínez, C. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1744004
Adolescent with cannabis use disorder and other mental health disorders: does dual disorder worsen school impairment?
Matalí, J. L., Flores, E., Estrada‐Prat, X., & Bonillo, A. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-026-00449-1
Characterizing Alcohol and Cannabis Co-use and Related Harms Among Transgender and Gender Diverse Youth
Penta, S. M., Uhrig, A., Wardell, J. D., Hart, T. A., & Dermody, S. S. (2026) · Prevention Science · doi:10.1007/s11121-026-01931-1

Authors: Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D.
Affiliations: The University of Queensland (AU)
LMU Klinikum (DE)
Dartmouth College (US)
Corresponding author: Connor, Jason P.
ORCID: Connor, Jason P.
Stjepanović, Daniel
Budney, Alan J.
Hall, Wayne D.
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2021-02-25
Volume: 7
Issue: 1
Pages: 16-16
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-021-00247-4
PMC: PMC8655458
OpenAlex: W3131397527
Cited by: 552
References: 341
Citations by year: 2026: 106 · 2025: 135 · 2024: 119 · 2023: 122 · 2022: 49 · 2021: 21
FWCI: 9.85
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (R01DA050032, T32DA037202, P30DA029926)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: cannabis use disorder, cannabis use, cognitive behavioral therapy, motivational enhancement therapy, contingency management, abstinence, cannabinoid receptor agonists, pharmacotherapy, psychiatric comorbidity, substance use disorders, cannabis legalization, medical cannabis, non-medical cannabis, public health burden
MeSH terms: Analgesics, Cannabis, Marijuana Abuse, Humans, Cognitive Behavioral Therapy, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabis use and cannabis use disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks